The emerging role of microbiota derived SCFAs in neurodegenerative disorders
Common Side Effects Gastrointestinal effects: Nausea, diarrhea, vomiting, and constipation top the list of adverse events
Semaglutide treatment at dosages from 0.5 mg to 2 mg weekly demonstrated variable efficacy, from preventing further weight gain in patient 1, to achieving weight loss of up to 14.4% and 11% relative to baseline, in Patient 2 and Patient 3
Copper peptides work well alongside hyaluronic acid, niacinamide, and gentle peptides, but can conflict with certain actives
A different study revealed that in 175 patients with overweight and obesity, the use of semaglutide led to a notable reduction in weight
Treatment Landscape Today, obesity therapies consist of lifestyle changes, surgery, and drugs like GLP-1 agonists